These results demonstrate that downregulation of MFN1 in the VTA dopaminergic Mor-Ens contributes to the induction of withdrawal symptoms and negative affects, including anxiety, depression, and reduced sociability during opiate withdrawal. This evidence concerns the gene MFN1 and depressive symptom measurement.